Morbidity and mortality of ischaemic heart disease in high-risk breast-cancer patients after adjuvant postmastectomy systemic treatment with or without radiotherapy: analysis of DBCG 82b and 82c randomised trials
- 1 October 1999
- journal article
- clinical trial
- Published by Elsevier in The Lancet
- Vol. 354 (9188) , 1425-1430
- https://doi.org/10.1016/s0140-6736(99)02245-x
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Postoperative Radiotherapy in High-Risk Premenopausal Women with Breast Cancer Who Receive Adjuvant ChemotherapyNew England Journal of Medicine, 1997
- Effects of Radiotherapy and Surgery in Early Breast Cancer — An Overview of the Randomized TrialsNew England Journal of Medicine, 1995
- Cardiac and vascular morbidity in women receiving adjuvant tamoxifen for breast cancer in a randomised trialBMJ, 1995
- Cardiac and Thromboembolic Morbidity Among Postmenopausal Women With Early Stage Breast Cancer in a Randomized Trial of Adjuvant TamoxifenJNCI Journal of the National Cancer Institute, 1993
- Cardiac doses in post-operative breast irradiationRadiotherapy and Oncology, 1992
- Cardiovascular mortality in a randomized trial of adjuvant radiation therapy versus surgery alone in primary breast cancerInternational Journal of Radiation Oncology*Biology*Physics, 1992
- Simple Mastectomy with Postoperative Irradiation Versus Extended Radical Mastectomy in Breast Cancer: A twenty-five-year follow-up of a randomized trialActa Oncologica, 1990
- Postoperative radiotherapy and late mortality: evidence from the Cancer Research Campaign trial for early breast cancer.BMJ, 1989
- Adjuvant Therapy of Premenopausal and Menopausal High-Risk Breast Cancer Patients: Present status of the Danish Breast Cancer Cooperative Group Trials 77-B and 82-BActa Oncologica, 1988
- Postmastectomy Irradiation in High-Risk Breast Cancer Patients: Present status of the Danish Breast Cancer Cooperative Group trialsActa Oncologica, 1988